OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 76 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,227 | +34.4% | 1,152 | -1.7% | 0.00% | – |
| Q2 2023 | $10,583 | +10378.2% | 1,172 | -96.0% | 0.00% | -100.0% |
| Q1 2023 | $101 | +320.8% | 29,150 | +197.7% | 0.00% | +200.0% |
| Q4 2022 | $24 | -99.9% | 9,792 | +32.7% | 0.00% | – |
| Q3 2022 | $20,000 | -39.4% | 7,378 | -9.2% | 0.00% | -100.0% |
| Q2 2022 | $33,000 | +32.0% | 8,126 | +36.4% | 0.00% | – |
| Q1 2022 | $25,000 | -60.9% | 5,956 | -13.3% | 0.00% | -100.0% |
| Q4 2021 | $64,000 | +611.1% | 6,871 | +1988.4% | 0.00% | – |
| Q3 2021 | $9,000 | -73.5% | 329 | -73.2% | 0.00% | -100.0% |
| Q2 2021 | $34,000 | -12.8% | 1,229 | +5.2% | 0.00% | 0.0% |
| Q1 2021 | $39,000 | +44.4% | 1,168 | +104.9% | 0.00% | 0.0% |
| Q4 2020 | $27,000 | – | 570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |